May 25, 2022
by Andrii Buvailo
News
Hong Kong-based clinical stage drug discovery company Insilico Medicine just announced the nomination of a novel preclinical drug candidate for …
May 17, 2022
by Andrii Buvailo
Biopharma insight
Artificial intelligence (AI) is undoubtedly a big deal in the pharmaceutical industry, bringing the unprecedented abilities of modeling biology at …
May 11, 2022
by Andrii Buvailo
Biopharma insight
Proteins are essential components of living matter – they function as building blocks for cells and tissues, as well as …
May 6, 2022
by Bohdana Sokolova, Andrii Buvailo
Biopharma insight
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
May 3, 2022
by Andrii Buvailo
Interview
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …
April 26, 2022
by Andrii Buvailo
Interview
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
March 22, 2022
by Andrii Buvailo
Interview
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Feb. 14, 2022
by Chris De Savi
Biopharma insight
Drug Discovery crystal ball gazing for the year ahead. And the hottest prospects are discussed below. We already have 5 …
Feb. 4, 2022
by Alan Nafiiev
Biopharma insight
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
Jan. 26, 2022
by Andrii Buvailo
Biopharma insight
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …